These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
507 related articles for article (PubMed ID: 29651507)
1. Efficacy and side effects of baclofen and the novel GABA Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507 [TBL] [Abstract][Full Text] [Related]
2. Suppressing effect of CMPPE, a new positive allosteric modulator of the GABA Maccioni P; Fara F; Lorrai I; Acciaro C; Mugnaini C; Corelli F; Colombo G Alcohol; 2019 Mar; 75():79-87. PubMed ID: 30468987 [TBL] [Abstract][Full Text] [Related]
3. The GABA Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133 [TBL] [Abstract][Full Text] [Related]
4. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Filip M; Frankowska M Eur J Pharmacol; 2007 Oct; 571(2-3):166-73. PubMed ID: 17610868 [TBL] [Abstract][Full Text] [Related]
5. Role of the GABA Sun W; Yuill MB Psychopharmacology (Berl); 2020 Dec; 237(12):3759-3771. PubMed ID: 32875348 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE). Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923 [TBL] [Abstract][Full Text] [Related]
7. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators]. Agabio R; Colombo G Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587 [TBL] [Abstract][Full Text] [Related]
8. GABA de Miguel E; Vekovischeva O; Kuokkanen K; Vesajoki M; Paasikoski N; Kaskinoro J; Myllymäki M; Lainiola M; Janhunen SK; Hyytiä P; Linden AM; Korpi ER Addict Biol; 2019 Nov; 24(6):1191-1203. PubMed ID: 30421860 [TBL] [Abstract][Full Text] [Related]
9. KK-92A, a novel GABA Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542 [TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder. Augier E Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865 [TBL] [Abstract][Full Text] [Related]
11. Positive allosteric modulators of the GABAB receptor: a new class of ligands with therapeutic potential for alcohol use disorder. Colombo G Alcohol Alcohol; 2024 Mar; 59(3):. PubMed ID: 38566580 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of the GABAΒ receptor agonist, baclofen, and the positive allosteric modulator of the GABAB receptor, GS39783, on alcohol self-administration in 3 different lines of alcohol-preferring rats. Maccioni P; Zaru A; Loi B; Lobina C; Carai MA; Gessa GL; Capra A; Mugnaini C; Pasquini S; Corelli F; Hyytiä P; Lumeng L; Colombo G Alcohol Clin Exp Res; 2012 Oct; 36(10):1748-66. PubMed ID: 22486245 [TBL] [Abstract][Full Text] [Related]
13. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Slattery DA; Markou A; Froestl W; Cryan JF Neuropsychopharmacology; 2005 Nov; 30(11):2065-72. PubMed ID: 15841108 [TBL] [Abstract][Full Text] [Related]
14. Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Smith MA; Yancey DL; Morgan D; Liu Y; Froestl W; Roberts DC Psychopharmacology (Berl); 2004 Apr; 173(1-2):105-11. PubMed ID: 14712341 [TBL] [Abstract][Full Text] [Related]
16. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen. Maccioni P; Fantini N; Froestl W; Carai MA; Gessa GL; Colombo G Alcohol Clin Exp Res; 2008 Sep; 32(9):1558-64. PubMed ID: 18616673 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen. Maccioni P; Vargiolu D; Thomas AW; Malherbe P; Mugnaini C; Corelli F; Leite-Morris KA; Gessa GL; Colombo G Psychopharmacology (Berl); 2015 May; 232(10):1831-41. PubMed ID: 25420609 [TBL] [Abstract][Full Text] [Related]
18. Potential of GABA Maccioni P; Colombo G CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283 [TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model. Brown JW; Moeller A; Schmidt M; Turner SC; Nimmrich V; Ma J; Rueter LE; van der Kam E; Zhang M Neuropharmacology; 2016 Feb; 101():358-69. PubMed ID: 26471422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]